Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis.

AIMS--To study the effect of proctocolectomy on the antineutrophil cytoplasmic antibody (ANCA) titres in association with ulcerative colitis. METHODS--Serum samples were taken from 15 patients with ulcerative colitis immediately before and at a mean of 24 months after proctocolectomy. Indirect immunofluorescence for ANCA and enzyme immunoassays for myeloperoxidase and proteinase-3 antibodies were employed. A liver biopsy was taken from every patient during the proctocolectomy, and serum liver enzyme activities were also determined. RESULTS--Before proctocolectomy, 13 of the 15 patients had perinuclear antineutrophil cytoplasmic antibodies (p-ANCA). Additionally, one patient had a low tire of classical cytoplasmic ANCA and one had granulocyte specific antinuclear antibodies. After proctocolectomy, the ANCA titres decreased in 10 patients, in two of whom they became negative. The titres remained the same in four patients with positive ANCA and increased twofold in one patient. Only one patient was proteinase-3 antibody positive and all 15 patients were myeloperoxidase antibody negative. The clinical condition improved in all patients, irrespective of the ANCA status after proctocolectomy. Seven patients, all of whom were positive for p-ANCA before proctocolectomy, had histological liver abnormalities. No correlation was observed between serum liver enzyme levels and ANCA staining patterns or titres. CONCLUSIONS--Proctocolectomy decreased the ANCA titres in the majority of our patients, suggesting that reduction of the inflammation or the available antigenic material modifies the immune disturbance related to ulcerative colitis.

[1]  J. Savige Detection of autoantibodies to neutrophil cytoplasmic antigens. , 1995, Journal of clinical pathology.

[2]  E. Soppi,et al.  The effect of proctocolectomy on serum antibody levels against cow's milk proteins in patients with chronic ulcerative colitis, with special reference to liver changes. , 1994, Scandinavian journal of gastroenterology.

[3]  R. Goldschmeding,et al.  Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. , 1994, Journal of clinical pathology.

[4]  J. Goeken ANCA in inflammatory bowel and liver diseases: New evidence for an autoimmune etiology? , 1993 .

[5]  F. Mitros,et al.  Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis. , 1993, American journal of clinical pathology.

[6]  R. Goldschmeding,et al.  Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. , 1993, Gut.

[7]  S. Chaussade,et al.  Antineutrophil cytoplasmic auto-antibodies in sera from patients with ulcerative colitis after proctocolectomy with ileo-anal anastomosis. , 1993, Advances in experimental medicine and biology.

[8]  J. Schölmerich,et al.  p-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy. , 1993, Advances in experimental medicine and biology.

[9]  R. Chapman,et al.  Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. , 1992, Gut.

[10]  H. Waldum Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. , 1992, Journal of hepatology.

[11]  M. Kamm,et al.  Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. , 1992, Gut.

[12]  F. Seibold,et al.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. , 1992, Gut.

[13]  S. Targan,et al.  Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. , 1991, Gastroenterology.

[14]  R. Wiesner,et al.  Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. , 1991, Gastroenterology.

[15]  J. Schölmerich,et al.  A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. , 1990, Immunobiology.

[16]  T. The,et al.  Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre , 1990, The Lancet.

[17]  S. Targan,et al.  A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. , 1990, The Journal of allergy and clinical immunology.

[18]  R. Falk,et al.  Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  J. Mustonen,et al.  Clinical significance of autoantibodies against neutrophil cytoplasmic components in patients with renal disease. , 1990, American journal of nephrology.

[20]  E. AriasVallejo Primary sclerosing cholangitis , 1988 .

[21]  T. H. The,et al.  AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS , 1985, The Lancet.

[22]  R. Wiesner,et al.  Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis , 1981, Hepatology.